Netherlands
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 97.85 B
|
Dec. 31, 2023 | USD 36.38 | 0.42% |
|
Netherlands |
|
2 |
USD 20.05 B
|
Dec. 31, 2023 | USD 27.32 | 1.49% |
|
Netherlands |
|
3 |
USD 1.99 B
|
Dec. 31, 2023 | USD 129.11 | 4.28% |
|
Netherlands |
|
4 |
USD 1.97 B
|
Dec. 31, 2023 | USD 44.64 | 0.29% |
|
Netherlands |
|
5 |
USD 1.23 B
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
|
6 |
USD 245.32 M
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
7 |
USD 43.95 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
8 |
USD 15.84 M
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
|
9 |
USD 12.76 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
10 |
USD 7.19 M
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
11 |
USD 6.77 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
12 |
USD 0.00
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
The Healthcare company in Netherlands with the highest Revenue is Koninklijke Ahold Delhaize N.V. (Amsterdam Stock Exchange: AD.AS) at USD 97.85 B.
The Healthcare company in Netherlands with the lowest Revenue is Pharvaris N.V. (NasdaqGS: PHVS) at USD 0.00.
The top 10 Healthcare companies in Netherlands by Revenue are Koninklijke Ahold Delhaize N.V., Koninklijke Philips N.V., Redcare Pharmacy NV, Qiagen N.V., argenx SE, Pharming Group N.V., Merus N.V., uniQure N.V., NewAmsterdam Pharma Company N.V. and ProQR Therapeutics N.V..
The bottom 10 Healthcare companies in Netherlands by Revenue are Pharvaris N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., NewAmsterdam Pharma Company N.V., uniQure N.V., Merus N.V., Pharming Group N.V., argenx SE, Qiagen N.V. and Redcare Pharmacy NV.